Latest Stock Market News

India s market correction influenced by both domestic and global factors presents a strong entry point for long-term investors. Focusing on quality stocks and avoiding sectors like automobiles and pharma could yield better returns. Investors are advised to allocate a significant portion to gold amidst global uncertainties.

Bharti Airtel shares: Airtel will leverage Nokia s automation framework to enable seamless service launches and efficient lifecycle management for core network functions. This will improve its capacity to introduce new services more quickly while lowering network operational expenses.

Rate this item

(1 Vote)

RIL shares: The first announcement reveals that Reliance has initiated the construction of its first Compressed Biogas (CBG) plant in Andhra Pradesh, as part of a broader plan to set up 500 CBG plants in the region.

Despite ample liquidity in the banking system, credit growth is weak due to low demand and slow policy transmission. Devang Shah of Axis MF explains that economic momentum is crucial for lending to rise. He predicts further rate cuts and expects credit growth to improve in the second half of 2025 as conditions stabilize.

As of now, 52 companies have received SEBI approval for their public issues, while a total of 65 firms have submitted draft IPO papers.

Indian benchmark indices, Sensex and Nifty 50, opened lower following the imposition of a 26% reciprocal tariff on Indian imports by US President Donald Trump. All major sectors declined, except for the pharma sector, with top IT firms like HCL Tech, Infosys, and TCS among the biggest losers.

US tariffs on Indian goods may indirectly impact India s IT sector by causing higher inflation and reduced tech spending in the US. Indian IT firms, which rely heavily on US clients, could face revenue declines if US companies cut their technology budgets due to the economic uncertainties.

The Trump administration s 26% tariff on Indian imports has led to significant market reactions and economic concerns. Pharmaceuticals remain exempt, but uncertainty looms. Key sectors such as automobiles and manufacturing face substantial challenges, while IT and services are relatively unaffected. Tariffs may impact overall GDP growth.

Rate this item

(1 Vote)

HDFC Securities recommends an Add call on Nykaa with a target price of Rs 180. Nykaa, a small cap in the services sector, reported a significant increase in Total Income and a net profit after tax. The valuation for the beauty and personal care business appears reasonable, with the fashion sector still under development. Promoters hold a 52.16% stake.

Shares of Indian pharma companies with significant US exposure surged by up to 14% after President Trump refrained from imposing new tariffs on the sector. While electronics and gems are hit by tariffs, pharmaceuticals remain exempt, boosting companies like Gland Pharma and Aurobindo Pharma.

Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.